Bright Minds Biosciences (DRUG) Prepaid Assets (2020 - 2026)

Bright Minds Biosciences (DRUG) has 7 years of Prepaid Assets data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Prepaid Assets rose 280.84% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 280.84% YoY) and the FY2025 annual result came in at $717850.7, up 352.05% from the prior year.
• Prepaid Assets advanced to $1.1 million in Q1 2026, from $887126.8 in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $1.1 million in Q1 2026 to a low of $11364.0 in Q1 2024.
• A 5-year average of $265504.1 and a median of $126075.3 in 2022 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2024 — Prepaid Assets plunged 91.41% — and 2025, when it soared 2361.59%.
• Tracing DRUG's Prepaid Assets over 5 years: stood at $116514.7 in 2022, then slumped by 79.78% to $23557.3 in 2023, then surged by 683.85% to $184653.3 in 2024, then jumped by 380.43% to $887126.8 in 2025, then increased by 20.09% to $1.1 million in 2026.
• The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), $887126.8 (Q4 2025), and $717850.7 (Q3 2025), per Business Quant data.